jRCT2080222514未知3 期
A General Clinical Pharmacological Study of TRK-820 Soft Capsules - Refractory Pruritus in Patients on Peritoneal Dialysis-
适应症
试验速览
- 阶段
- 3 期
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 干预模型
- Open-label study
入排标准
- 年龄范围
- 20age old over 至 No limit（—）
- 性别
- All
入选标准
- •(1)Patients on Peritoneal Dialysis
- •(2)It can be confirmed that the treatment of pruritus with existing therapies such as antihistamines or antiallergics has not been adequately effective in such patients
排除标准
- 未提供
结局指标
主要结局
-
Changes in the VAS values
次要结局
未报告次要终点
研究者
相似试验
未知
3 期
A General Clinical Pharmacological Study of TRK-820 Soft Capsules - Refractory Pruritus in Patients on Peritoneal DialysisIntractable Pruritus in Patients on Peritoneal DialysisJPRN-jRCT2080222514Toray Industries,Inc.
未知
1 期
Clinical pharmacology study of K-877DyslipidemiaJPRN-jRCT2080222359Kowa Co., Ltd.32
未知
1 期
Pharmacokinetic study of TRK-820 -Pharmacokinetic study among TRK-820 tablets and TRK-820 soft capsules.Healthy Japanese MaleJPRN-jRCT1080221878Toray Industries,Inc.8
未知
1 期
clinical pharmacology study of K-877DyslipidemiaJPRN-jRCT2080222360Kowa Co., Ltd.24
未知
1 期
A phase I clinical pharmacology study of TAK-233 in healthy subjectsHealthy adult female subjectsJPRN-jRCT2080222396TAKEDA PHARMACEUTICAL COMPANY LTD.24